Clinical Trials Search Results Display: Title Description with: Locations Eligibility Full Trial Description Custom ? Hide Search Criteria Show Search Criteria Drug: MELK inhibitor OTS167Find trials that include: Any drugs shown Results 1-2 of 2 for your search: Start Over Select All on Page Sort by: Phase of Trial Title Type of Trial Status of Trial Age Range Trial ID Show 10 25 50 100 200 Results per Page 1. Pharmacological Study of Intravenous OTS167 in Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Advanced Myelodysplastic Syndromes, Advanced Myeloproliferative Neoplastic Disorders, or Advanced Chronic Myelogenous Leukemia Status: ActivePhase: Phase II, Phase IType: TreatmentAge: 18 and overTrial IDs: OTS167-SE02, NCI-2016-01054, NCT02795520 2. Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer Status: ActivePhase: Phase IType: TreatmentAge: 18 and overTrial IDs: OTS1070103, NCI-2017-00301, NCT02926690 Select All on Page Start Over
